FindTrial
Sign In

Application of Growth Hormone in Patients with Poor Ovarian Response and Study of Mechanism

Application of Growth Hormone in Patients with Poor Ovarian Response and Study of Mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016106
Enrollment
Unknown
Registered
2018-05-11
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

A:GH 4.5IU/d subcutaneous injection every day from the menstrual day before last menstruation period
B:GH 4.5IU/d subcutaneous injection every day from initiation day to trigger day.
C:No use of Growth Hormone

Sponsors

Sichuan Provincial Hospital For Woman and Children
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 44 Years

Inclusion criteria

Inclusion criteria: Patients with poor ovarian response who recieved IVF-ET in our reproductive center.

Exclusion criteria

Exclusion criteria: 1. BMI=29 or 15IU/ml; 8. Chromosomal abnormalities; 9. Patients whose husband need spercutaneous epididymal sperm aspiration or testicular sperm extraction.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;follicular fluid level of estradiol;mRNA of FSH receptor in granular cell;—

Secondary

MeasureTime frame
Gonadotropins usage duration;—

Countries

China

Contacts

Public ContactYan Gong

Sichuan Provincial Hospital For Woman and Children

gongyan_496181657@qq.com+86 15208393996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026